Month: March 2021
MD Anderson’s Therapeutics Discovery division, Orionis Biosciences launch Project Helios to advance novel small-molecule cancer medicines
Orionis Biosciences and MD Anderson Cancer Center announce the launch of Project Helios, a research collaboration designed to unlock new drug development opportunities through genome-scale mapping of drug-target interactions….